Combo of virotherapy and radiotherapy shows early promise in patients with esophageal cancer
ATLANTA -- The experimental oncolytic adenovirus telomelysin (OBP-301) in combination with radiotherapy was safe and showed early clinical efficacy in vulnerable patients with esophageal cancer,...













